Condition: Psychological Stress · Depression · Anxiety · Sponsor: Rachel Yehuda
This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders. The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.
This description comes directly from the study's public registry record.
Lauren Lepow, MD, PhD · 646-438-5044 · lauren.lepow@mountsinai.org
Evelyn Alkin, MA · 929-489-7440 · IntergenStudy@mssm.edu
Always discuss trial participation with your own doctor first.
| The Parsons Research Center for Psychedelic Healing | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06899165